Intellia Therapeutics, Inc. (NASDAQ:NTLA) has 298 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 31 Mar, 2026 | 14,509,247 | 301,923 | 2.13% | $186,008,545.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 12,155,806 | 1,878,957 | 18.28% | $155,837,437.00 |
| State Street Corp | 31 Mar, 2026 | 6,922,676 | 503,840 | 7.85% | $88,748,706.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 6,223,325 | 6,223,325 | 0.00% | $79,783,027.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 5,728,177 | 397,113 | 7.45% | $73,435,230.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 5,084,105 | 5,084,105 | 0.00% | $65,178,226.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 4,705,901 | 2,007,163 | 74.37% | $60,329,651.00 |
| Regeneron Pharmaceuticals, Inc. | 31 Mar, 2026 | 3,702,995 | 0 | 0.00% | $47,472,396.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,851,472 | 155,285 | 5.76% | $36,563,024.00 |
| UBS Group AG | 31 Mar, 2026 | 2,689,486 | 1,829,934 | 212.89% | $34,479,209.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 2,318,110 | 386,261 | 19.99% | $29,708,722.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,081,397 | -246,455 | -10.59% | $26,683,520.00 |
| FMR LLC | 31 Mar, 2026 | 2,067,222 | 307,324 | 17.46% | $26,501,787.00 |
| Sumitomo Mitsui Trust Group, Inc. | 31 Mar, 2026 | 1,973,061 | -219,400 | -10.01% | $25,294,642.00 |
| Amova Asset Management Americas, Inc. | 31 Mar, 2026 | 1,973,061 | -219,400 | -10.01% | $25,274,911.00 |
| Contrarius Group Holdings Ltd | 31 Mar, 2026 | 1,911,839 | 1,197,359 | 167.58% | $24,509,776.00 |
| JUPITER ASSET MANAGEMENT LTD | 31 Mar, 2026 | 1,781,063 | 743,145 | 71.60% | $22,833,228.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,628,241 | -1,282,997 | -44.07% | $20,874,050.00 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 31 Mar, 2026 | 1,611,534 | -125,916 | -7.25% | $20,659,866.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Mar, 2026 | 1,397,243 | 1,397,243 | 0.00% | $17,912,655.00 |